Gianni Colotti

17PUBLICATIONS
64CO-AUTHORS
Biomolecular modelling and designMolecular targetsCancer geneticsGene and molecular therapyAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 26, 2026
UbC4 from Leishmania is a Druggable E2 Ubiquitin Conjugating Enzyme: Structural Basis and Fragment Hits for Future E2-Recruiting PROTAC Development.

|Mar 25, 2026
The ATC12 small molecule inhibits the Aurora-A/TPX2 interaction and impairs the proliferation of breast cancer cells.

Dalila Boi, Giulia Fianco, Federica Polverino

|Feb 21, 2026
α-ketoglutarate/succinate ratio imbalance impairs thymine DNA glycosylase function and base excision repair process increasing susceptibility to pancreatic cancer.

Silvia Malatesta, Virginia Vigiano Benedetti, Emanuela Salviati

|Aug 29, 2024
Sorcin in Cancer Development and Chemotherapeutic Drug Resistance.

Cécile Exertier, Lorenzo Antonelli, Annarita Fiorillo

|Apr 13, 2024
Nose-to-brain selective drug delivery to glioma via ferritin-based nanovectors reduces tumor growth and improves survival rate.

Francesco Marrocco, Elisabetta Falvo, Luciana Mosca

|Jul 13, 2023
Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in Cancer Cells.

Clemens Zwergel, Michele Aventaggiato, Sabrina Garbo

Pageof 3

Frequent Collaborators

10 joint publications

Andrea Ilari

6 joint publications

Annarita Fiorillo

4 joint publications

Cécile Exertier

2 joint publications

Theo Battista